E. Hubmann

Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.

P. Regitnig, A. Porwit, G. Hoefler, 2014, Archives of pathology & laboratory medicine.

Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma

M. Pichler, T. Bauernhofer, F. Keil, 2013, Acta oncologica.

Neoadjuvant FOLFIRINOX in pancreatic cancer 1231

M. Pichler, T. Bauernhofer, G. Leitner, 2013 .

Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.

H. Neumann, A. Gerger, G. Prager, 2020, European journal of cancer.

Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.

U. Jaeger, D. Niederwieser, P. Kyrle, 1997, Blood.

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study

R. Greil, H. Neumann, A. Gerger, 2020, Therapeutic advances in medical oncology.

Acquired elliptocytosis as presenting sign of a myelodysplastic syndrome associated with deletion of chromosome 20 and mutations in TET2, DNMT3A, and U2AF1

G. Hoefler, K. Aubell, C. Robier, 2021, Annals of Hematology.

Atypical “hairy cell-like” presentation of leukemic mantle cell lymphoma

G. Hoefler, M. Egger, C. Robier, 2018, Clinical chemistry and laboratory medicine.